We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AstraZeneca Begins Human Trials of COVID-19 Monoclonal Antibody
AstraZeneca Begins Human Trials of COVID-19 Monoclonal Antibody
AstraZeneca has dosed the first participants in a phase 1 trial of its investigational monoclonal antibody product AZD7442 for preventing and treating COVID-19.